Amgen (AMGN) - Company Gross Revenue

Amgen Inc. relies on stable demand for therapies that remain independent of economic crises. The company's trading revenue on the GURU.Markets chart is reflected via 38.98, which represents the latest metric reading. This helps the company counter the expansion of cheap generics through the acquisition of startups. The business's success is bolstered by a strong HR brand that retains leading geneticists and experts in rare pathologies.

Amgen Corporation - AMGN Revenue and Sales Volume (period 07/04/2022 - 11/15/2026)

Analytical breakdowns for Amgen Inc.

- current price and projected stock value:

Share Price Amgen Inc.|AMGN - Analyst Consensus Forecast

- market capitalization indicators:

Market Capitalization Amgen Corporation|AMGN - Total Company Value

- book capitalization data:

Equity per Share Amgen|AMGN - Book Capitalization|Market Value to Equity Ratio amgen.com|AMGN - Company Total Assets

- company liabilities and liquidity data:

- financial results and valuation multiples details:

AMGN - Net Income|Expected Net Income Amgen Inc.|AMGN - P/E Multiple|Market Cap to Projected Earnings Amgen Corp|AMGN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Amgen Corp|AMGN - Operating profit EBITDA|Net earnings per share for the last 12 months Amgen|AMGN - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months amgen.com|AMGN - Earnings growth in current year|Earnings growth forecast for next year Amgen Inc.

- company sales and revenue statistics:

AMGN - Company Revenue|Company Future Sales Volume Amgen Inc.|AMGN - P/S Multiple|Projected Price to Revenue Amgen Corporation|AMGN - Sales Growth YoY (Last Twelve Months)

Summary company analysis:AMGN - Amgen Inc.

For Amgen Inc. (AMGN), a leading biotech player amidst patent wars, corporate sales serve as an indicator of resilience against biosimilar pressure. This metric separates short-term market noise from the long-term fundamental trend of business development. The calculation is based on normalizing total revenue to a daily average to analyze the dynamics of cash inflows. Growth in these indicators confirms the effectiveness of R&D investments. This asset belongs to the high-tech securities class.

Key competitors